icotrokinra
icotrokinra: 4 clinical trials tracked.
icotrokinra evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about icotrokinra, and what remains unknown?
Traceable citations · Unknowns marked
Clinical Trial Registry Records (4)
A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Primary endpoint: Induction Study 1: Number of Participants with Clinical Response at Week 12
A Phase 3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol in Adults With an Open Label Study in Adolescents to Evaluate the Efficacy and Safety of Induction and Maintenance Therapy With Icotrokinra in Participants With Moderately to Severely Active Ulcerative Colitis
Primary endpoint: Double-blind (DB) Induction Study: Percentage of Adult Participants in Clinical Remission at Week I-12
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-naïve Participants With Active Psoriatic Arthritis
Primary endpoint: Proportion of Participants who Achieve an American College of Rheumatology (ACR) ACR 20 Response at Week 16
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Primary endpoint: Proportion of Participants who Achieved an American College of Rheumatology (ACR) 20 Response at Week 16